CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 77335 | prEN ISO 18969 | Clinical evaluation of medical devices (ISO/DIS 18969:2025) | Aptauja slēgta |
| 77933 | prEN ISO 10993-11 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2025) | Aptauja slēgta |
| 22089 | EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
| 67095 | LVS EN ISO 10993-12:2021 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021) | Standarts spēkā |
| 78993 | EN ISO 10993-23:2021/A1:2025 | Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/Amd 1:2025) | Standarts spēkā |
| 67767 | LVS EN ISO 10993-17:2023 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023) | Standarts spēkā |
| 79539 | LVS EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Standarts spēkā |
| 60722 | LVS EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019) | Standarts spēkā |
| 65480 | LVS EN ISO 22442-1:2021 | Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1:2020) | Standarts spēkā |
| 60725 | LVS EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | Standarts spēkā |
Displaying 131-140 of 194 results.